SCIENTIFIC ADVISOR AGREEMENTScientific Advisor Agreement • December 31st, 2015 • Zosano Pharma Corp • Pharmaceutical preparations • Delaware
THIS SCIENTIFIC ADVISOR AGREEMENT (this “Agreement”) is made and entered into as of December 31, 2015 (the “Effective Date”), by and among Zosano Pharma Corporation, a Delaware corporation having its principal place of business at 34790 Ardentech Court, Fremont, California 94555 (the “Parent”), ZP Opco, Inc., a Delaware corporation and wholly owned subsidiary of Parent (the “Company”), and PETER DADDONA, an individual residing at 35 Anderson Way, Menlo Park, California 94025 (the “Advisor”). The Parent, Company and Advisor may be referred to herein individually as a “Party” or collectively as the “Parties.”
SCIENTIFIC ADVISOR AGREEMENTScientific Advisor Agreement • March 7th, 2018 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS SCIENTIFIC ADVISOR AGREEMENT (the “Agreement”) is made and entered into this 1st day of June 2017 (the “Effective Date”) by and between Idera Pharmaceuticals, Inc., having a place of business at 167 Sidney Street, Cambridge, Massachusetts 02139, USA (hereinafter referred to as “Idera”) and Sudhir Agrawal, of Shrewsbury, Massachusetts (hereinafter referred to as the “Advisor”). Idera and Advisor may be referred to herein individually as a “Party” and collectively as the “Parties.”
EXHIBIT 10.17Scientific Advisor Agreement • March 28th, 2007 • Teeka Tan Products, Inc. • Perfumes, cosmetics & other toilet preparations • Florida
RIBOGENE, INC. SCIENTIFIC ADVISOR AGREEMENTScientific Advisor Agreement • October 27th, 1997 • Ribogene Inc / Ca/ • California
PROVENTION BIO, INC. SCIENTIFIC ADVISOR AGREEMENTScientific Advisor Agreement • June 3rd, 2022 • Provention Bio, Inc. • Pharmaceutical preparations • New Jersey
THIS SCIENTIFIC ADVISOR AGREEMENT (this “Agreement”) is made effective as of June 1, 2022 (the “Effective Date”), by and between by and between PROVENTION BIO, INC., a Delaware corporation (the “Company”), and Dr. Jeffrey Bluestone, PhD (the “Advisor”; together with the Company, collectively the “Parties”, and individually, a “Party”).
